Medpulser
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Medpulser, covering 2022-03-04 to 2022-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma [Phase 3]